Angiogenesis Inhibitors in the treatment of Prostate Cancer

Por Kluetz, Paul G., Figg, William D., Dahut, William L.
Publicado em 2010

Accumulating Evidence for a Drug–Drug Interaction Between Methotrexate and Proton Pump Inhibitors

Por Bezabeh, Shewit, Mackey, Ann Corken, Kluetz, Paul, Jappar, Dilara, Korvick, Joyce
Publicado em 2012

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies

Por Blumenthal, Gideon M., Kluetz, Paul G., Schneider, Julie, Goldberg, Kirsten B., McKee, Amy E., Pazdur, Richard
Publicado no Oncologist (2017)

Successes and Challenges of PARP Inhibitors in Cancer Therapy

Por Ricks, Tiffany K., Chiu, Haw-Jyh, Ison, Gwynn, Kim, Geoffrey, McKee, Amy E., Kluetz, Paul, Pazdur, Richard
Publicado no Front Oncol (2015)

U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based...

Por Larkins, Erin, Scepura, Barbara, Blumenthal, Gideon M., Bloomquist, Erik, Tang, Shenghui, Biable, Missiratch, Kluetz, Paul, Keegan, Patricia, Pazdur, Richard
Publicado no Oncologist (2015)

A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer

Por English, Bevin C, Baum, Caitlin E, Adelberg, David E, Sissung, Tristan M, Kluetz, Paul G, Dahut, William L, Price, Douglas K, Figg, William D
Publicado em 2010

‘Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials’- Authors Response to Letter

Por Kluetz, Paul G., Papadopoulos, Elektra J., Johnson, Laura Lee, Donoghue, Martha, Kwitkowski, Virginia E., Chen, Wen-Hung, Sridhara, Rajeshwari, Farrell, Ann T., Keegan, Patricia, Kim, Geoffrey, Pazdur, Richard
Publicado no Clin Cancer Res (2016)

US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments

Por Wedam, Suparna B., Beaver, Julia A., Amiri-Kordestani, Laleh, Bloomquist, Erik, Tang, Shenghui, Goldberg, Kirsten B., Sridhara, Rajeshwari, Ibrahim, Amna, Kim, Geoffrey, Kluetz, Paul, McKee, Amy, Pazdur, Richard
Publicado no J Clin Oncol (2018)

Clinical Development of Novel Drug-Radiotherapy Combinations

Por Ahmad, Saif S., Crittenden, Marka R., Tran, Phuoc T., Kluetz, Paul G., Blumenthal, Gideon M., Bulbeck, Helen, Baird, Richard D, Williams, Kaye J, Illidge, Tim, Hahn, Stephen M., Lawrence, Theodore S., Spears, Patricia A., Walker, Amanda J., Sharma, Ricky A.
Publicado no Clin Cancer Res (2018)

Beyond Maximum Grade: Modernizing Adverse Event Assessment and Reporting in Haematologic Malignancies

Por Thanarajasingam, Gita, Minasian, Lori M., Baron, Frederic, Cavalli, Franco, De Claro, R. Angelo, Dueck, Amylou C., El-Galaly, Tarec C., Everest, Neil, Geissler, Jan, Gisselbrecht, Christian, Gribben, John, Horowitz, Mary, Ivy, S. Percy, Jacobson, Caron A., Keating, Armand, Kluetz, Paul G., Krauss, Aviva, Kwong, Yok Lam, Little, Richard F., Mahon, Francois-Xavier, Matasar, Matthew J., Mateos, Maria Victoria, McCullough, Kristen, Miller, Robert S., Mohty, Mohamad, Moreau, Philippe, Morton, Lindsay M., Nagai, Sumimasa, Rule, Simon, Sloan, Jeff, Sonneveld, Pieter, Thompson, Carrie A., Tzogani, Kyriaki, van Leeuwen, Flora, Velikova, Galina, Villa, Diego, Wingard, John R., Wintrich, Sophie, Seymour, John F., Habermann, Thomas M.
Publicado no Lancet Haematol (2018)